Name: ____________________________ Date: _______________
Review of cerebral physiology and induction drugs, droperidol, benzodiazepine solubility and sedation, and flumazenil reversal.
Learning objectives
- Integrate cerebral perfusion and induction-drug effects.
- Describe droperidol's antiemetic action and QT concern.
- Explain midazolam's pH-dependent solubility and clinical behavior.
- Use flumazenil principles to anticipate reversal and resedation.
Complete the blanks as you watch. Use the time ranges to pause, review and discuss the key ideas with your faculty.
00:00 to 25:00
Cerebral Review
- Cerebral perfusion pressure is approximately mean arterial pressure minus ________________.
- Propofol and etomidate generally reduce cerebral ________________ and blood flow.
- A drug's cerebral benefit can be offset if systemic hypotension reduces ________________ pressure.
- Ketamine's cerebral effects must be interpreted with ________________, dose, and clinical context.
25:00 to 45:00
Droperidol
- Droperidol produces antiemetic effects largely through dopamine ________________ blockade.
- It can also produce sedation and ________________ blockade.
- The boxed warning emphasizes QT ________________ and risk of serious ventricular arrhythmia.
- Dose, patient risk factors, other ________________ drugs, and monitoring shape safe use.
45:00 to 60:00
Benzodiazepine Solubility
- Midazolam is water soluble in an acidic vial because its ring is ________________.
- At physiologic pH the ring closes, increasing lipid solubility and ________________ entry.
- This ________________ chemistry supports convenient injection and rapid brain penetration.
- Midazolam produces anxiolysis, sedation, and amnesia but limited ________________.
60:00 to 72:00
Clinical Sedation
- Benzodiazepine effects are amplified by opioids and other ________________ depressants.
- Combined sedation can produce clinically important ________________.
- Older or frail patients often require smaller, slower, ________________ doses.
- Observation must continue until ________________, responsiveness, and protective function are stable.
72:00 to 78:42
Flumazenil
- Flumazenil is a competitive antagonist at the benzodiazepine site on the ________________.
- It can reverse benzodiazepine sedation but not ________________ effects.
- Its duration may be shorter than the ________________, creating a risk of resedation.
- Abrupt reversal can ________________ seizures or withdrawal in susceptible patients.
Notes & questions for class
Lecture recorded in 2017. Use current local protocols and faculty guidance for clinical decisions.